Congenital falciparum malaria 先天性恶性疟
Plasmodium falciparum malaria 恶性疟疾 ; 恶性疟
Imported falciparum malaria 输入性恶性疟
falciparum malaria infections 恶性疟
drug resistant falciparum malaria 抗药性恶性疟
multidrug resistant falciparum malaria 多重抗性恶性疟
chloroquine resistant falciparum malaria 抗氯喹株恶性疟
Objective To provide a combined medication scheme for the treatment of multi-drug resistant falciparum malaria. . Methods.
目的 寻找更理想的治疗抗药性恶性疟的联合用药方案。
参考来源 - 双氢青蒿素与咯萘啶伍用治疗抗性恶性疟的研究·2,447,543篇论文数据，部分数据来源于NoteExpress
Conclusion Naphthoquine phosphate is effective for the treatment of patients with Plasmodium falciparum malaria.
结论：磷酸萘酚喹治疗恶性疟疾具有良好的效果。
Objective To evaluate the clinical efficacy of dihydroartemisinin—mefloquine on acute uncomplicated falciparum malaria.
目的观察双氢青蒿素与甲氟喹联用治疗急性无并发症恶性疟疾的临床疗效。
WHO's treatment policy is to treat all cases of uncomplicated falciparum malaria with artemisinin combination therapy (ACTs).
世卫组织的治疗政策是，应采用青蒿素联合治疗药物来治疗一切无并发症的恶性疟疾病例。
应用推荐